📊 Score Breakdown
Offering Ability
40
Cash Runway
10
Float Risk
40
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
7%
📉 Score Deterioration
15%
• Score climbed 5 points (worsening)
💹 Market Data
Market Cap$39.09B
Shares Outstanding1.24B
FloatN/A
Cash$1.42B
Debt$25.29B
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 56.9% shares (2026Q1 vs prior)
10 institutional holders · 427.66M shares
#1
Vanguard Group Inc
128.13M shares
#2
Blackrock Inc.
79.17M shares
#3
State Street Corporation
47.37M shares
+ 7 more holders Sign up free to view →
📉 Short Interest
Short Interest43.87M
Days to Cover1.8
% of FloatN/A
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Nov 30, 2024
4
INSIDER TRANSACTION
Apr 02, 2026
424B3
ATM
Feb 27, 2026
EFFECT
EFFECT
Feb 27, 2026
4
INSIDER TRANSACTION
Feb 12, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for CCL
📊 CCL FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 CCL Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.